The effect of chronic administration of safranal on systolic blood pressure in rats. 2015

Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
Pharmaceutical Research Center, Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated. Three doses of safranal (1, 2 and 4 mg/Kg/day) and spironolactone (50 mg/Kg/day) were administrated to the different groups of normotensive and hypertensive rats (at the end of 4 weeks treatment by DOCA-salt) for Five weeks. Then the effects of safranal on mean systolic blood pressure (MSBP) and heart rate (HR) were evaluated using tail cuff method. The duration of effect of safranal on SBP, was also evaluated. Our results indicated that chronic administration of safranal could reduce the MSBP in DOCA salt treated rats in a dose dependent manner. Safranal did not decrease the MSBP in normotensive rats. The data also showed that antihypertensive effects of safranal did not persist. In summary, our results showed that safranal exhibits antihypertensive and normalizing effect on BP in chronic administration.

UI MeSH Term Description Entries

Related Publications

Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
January 1992, Life sciences,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
February 2002, Pharmacology,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
August 1973, Toxicology and applied pharmacology,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
June 1994, Hypertension (Dallas, Tex. : 1979),
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
June 2007, Blood pressure monitoring,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
January 2003, Clinical therapeutics,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
November 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
April 1993, Nihon Jinzo Gakkai shi,
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
January 2009, Heart (British Cardiac Society),
Mohsen Imenshahidi, and Bibi Marjan Razavi, and Ayyoob Faal, and Ali Gholampoor, and Seyed Mehran Mousavi, and Hossein Hosseinzadeh
December 1981, The Journal of tropical medicine and hygiene,
Copied contents to your clipboard!